Tuesday, October 16, 2012

Nearly one-third of kidney transplant patients readmitted to hospital within 30 days

Nearly one-third of kidney transplant patients readmitted to hospital within 30 days [ Back to EurekAlert! ] Public release date: 16-Oct-2012
[ | E-mail | Share Share ]

Contact: Stephanie Desmon
sdesmon1@jhmi.edu
410-955-8665
Johns Hopkins Medicine

'Extremely high risk' of return requires focus on outpatient management, Johns Hopkins researchers say

Three in 10 patients receiving a kidney transplant require readmission to the hospital within 30 days of discharge following surgery, according to a Johns Hopkins analysis of six years of national data.

The findings, published online in the American Journal of Transplantation, suggest more needs to be done to manage patients outside the hospital to keep them from costly and potentially preventable return visits. Readmissions are said to cost the U.S. health care system $25 billion a year. The Centers for Medicare and Medicaid Services has begun the process of decreasing reimbursements to hospitals with high readmission rates, using readmissions as a surrogate measure of hospital quality.

"We need to be aware that kidney transplant recipients have an extremely high risk of returning to the hospital in the first 30 days after discharge, and that readmissions may very well be prevented by putting in place better systems for outpatient management," says study leader Dorry L. Segev, M.D., Ph.D., an associate professor of surgery at the Johns Hopkins University School of Medicine. "Some patients just need more intense monitoring."

Segev and his colleagues examined data provided by the Organ Procurement and Transplantation Network, Medicare, and the United States Renal Data System from more than 32,000 patients who received kidney transplants in U.S. hospitals between Jan. 1, 2000 and Dec. 31, 2005. While 31 percent of transplant recipients required readmission within 30 days, the percent of patients returning varied by hospital, from 18 percent to nearly 50 percent, a variation that could not be accounted for by conventional issues of center volume or demographics.

Age, race, body mass index, diabetes, heart disease and several other factors were associated with early hospital readmission. African-Americans had an 11 percent increased risk of readmission, and obese patients had a 15 percent increased risk, while diabetic women were at a 29 percent increased risk. Interestingly, those patients who stayed in the hospital for five or more days at the time of their transplants were more likely to be readmitted within 30 days. Segev says this may be a sign that the more complex cases early on appear to remain complex and more likely to require additional care.

Patients who bounce back to the hospital are not returning only for complications related to their new organs such as infections or problems related to immunosuppressant drugs they need to keep from rejecting the new organ but often for problems related to other illnesses they had before they received their transplants. Segev says even though medical teams make sure that the heart disease or diabetes a transplant candidate may have is stable before a transplant takes place, those conditions can still cause complications after surgery. The entire medical team needs to be sure people with co-morbidities are very closely followed, he says.

"Kidney transplant is complex and the management of the first 30 days is complex," he adds. "We will never get the readmission rate down to zero, but it's highly likely we can get it down from nearly one-third."

Segev says he hopes that transplant centers with higher rates of readmission can learn lessons from centers with lower rates. They may find that those centers schedule more frequent outpatient visits, offer more opportunities to communicate with clinicians via email or the telephone, or are better at coordinating services such as blood work that may be needed after discharge so that critical post-transplant medication adjustments can be made quickly before a readmission is required.

###

Other Johns Hopkins researchers involved in the study include Mara A. McAdams-DeMarco, Ph.D.; Morgan E. Grams, M.D., M.H.S.; Erin Carlyle Hall, M.D., M.P.H.; and Josef Coresh, M.D.

The study was supported by grants from the National Kidney Foundation of Maryland, the American Federation for Aging Research, the National Institutes of Health's National Institute on Aging (K23AG032885) and NIH's National Institute of Diabetes and Digestive and Kidney Diseases (R21DK085409).

For more information: http://www.hopkinsmedicine.org/transplant/


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Nearly one-third of kidney transplant patients readmitted to hospital within 30 days [ Back to EurekAlert! ] Public release date: 16-Oct-2012
[ | E-mail | Share Share ]

Contact: Stephanie Desmon
sdesmon1@jhmi.edu
410-955-8665
Johns Hopkins Medicine

'Extremely high risk' of return requires focus on outpatient management, Johns Hopkins researchers say

Three in 10 patients receiving a kidney transplant require readmission to the hospital within 30 days of discharge following surgery, according to a Johns Hopkins analysis of six years of national data.

The findings, published online in the American Journal of Transplantation, suggest more needs to be done to manage patients outside the hospital to keep them from costly and potentially preventable return visits. Readmissions are said to cost the U.S. health care system $25 billion a year. The Centers for Medicare and Medicaid Services has begun the process of decreasing reimbursements to hospitals with high readmission rates, using readmissions as a surrogate measure of hospital quality.

"We need to be aware that kidney transplant recipients have an extremely high risk of returning to the hospital in the first 30 days after discharge, and that readmissions may very well be prevented by putting in place better systems for outpatient management," says study leader Dorry L. Segev, M.D., Ph.D., an associate professor of surgery at the Johns Hopkins University School of Medicine. "Some patients just need more intense monitoring."

Segev and his colleagues examined data provided by the Organ Procurement and Transplantation Network, Medicare, and the United States Renal Data System from more than 32,000 patients who received kidney transplants in U.S. hospitals between Jan. 1, 2000 and Dec. 31, 2005. While 31 percent of transplant recipients required readmission within 30 days, the percent of patients returning varied by hospital, from 18 percent to nearly 50 percent, a variation that could not be accounted for by conventional issues of center volume or demographics.

Age, race, body mass index, diabetes, heart disease and several other factors were associated with early hospital readmission. African-Americans had an 11 percent increased risk of readmission, and obese patients had a 15 percent increased risk, while diabetic women were at a 29 percent increased risk. Interestingly, those patients who stayed in the hospital for five or more days at the time of their transplants were more likely to be readmitted within 30 days. Segev says this may be a sign that the more complex cases early on appear to remain complex and more likely to require additional care.

Patients who bounce back to the hospital are not returning only for complications related to their new organs such as infections or problems related to immunosuppressant drugs they need to keep from rejecting the new organ but often for problems related to other illnesses they had before they received their transplants. Segev says even though medical teams make sure that the heart disease or diabetes a transplant candidate may have is stable before a transplant takes place, those conditions can still cause complications after surgery. The entire medical team needs to be sure people with co-morbidities are very closely followed, he says.

"Kidney transplant is complex and the management of the first 30 days is complex," he adds. "We will never get the readmission rate down to zero, but it's highly likely we can get it down from nearly one-third."

Segev says he hopes that transplant centers with higher rates of readmission can learn lessons from centers with lower rates. They may find that those centers schedule more frequent outpatient visits, offer more opportunities to communicate with clinicians via email or the telephone, or are better at coordinating services such as blood work that may be needed after discharge so that critical post-transplant medication adjustments can be made quickly before a readmission is required.

###

Other Johns Hopkins researchers involved in the study include Mara A. McAdams-DeMarco, Ph.D.; Morgan E. Grams, M.D., M.H.S.; Erin Carlyle Hall, M.D., M.P.H.; and Josef Coresh, M.D.

The study was supported by grants from the National Kidney Foundation of Maryland, the American Federation for Aging Research, the National Institutes of Health's National Institute on Aging (K23AG032885) and NIH's National Institute of Diabetes and Digestive and Kidney Diseases (R21DK085409).

For more information: http://www.hopkinsmedicine.org/transplant/


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Source: http://www.eurekalert.org/pub_releases/2012-10/jhm-noo101512.php

ridiculously photogenic guy amanda bynes dui ghost ship tiger woods masters jet crash virginia beach petrino clayton kershaw

Proteins in DNA damage response network targeted for new therapies, researchers say

ScienceDaily (Oct. 16, 2012) ? Researchers at Moffitt Cancer Center and colleagues at the University of South Florida; Duke University; Johns Hopkins University; the Brazilian National Cancer Institute; and the Rio de Janeiro Federal Institute of Education, Science and Technology have discovered that an intricate system to repair DNA damage called the "DNA damage response" (DDR) contains previously unknown components, including proteins that could be targeted as sensitizers for chemotherapy. Some of these targets may already have drugs available that have unrecognized uses in cancer therapy, said the researchers.

The study appears in the Sept. 18 issue of Science Signaling.

"A domain called BRCT is frequently present in proteins involved in the DDR network," said study lead author Alvaro N.A. Monteiro, Ph.D., senior member of Moffitt's Cancer Epidemiology Program. "We undertook a systematic analysis of the BRCT domain, a protein module that plays a critical role in the DDR, and found a large network of interacting proteins centered on BRCT-containing proteins. In doing so, we discovered new potential players in the DDR. These new players may constitute potential biomarkers for drug response or targets for treatment."

According to the authors, their data could be used to build a more comprehensive map of the components and interactions involved in the DDR, a system through which proteins detect DNA damage, promote repair and coordinate the cell cycle.

Because defects in the DDR can lead to cancer, the properly functioning network is considered to be a barrier against tumor growth. Chemotherapy regimens exploit weaknesses in the system to kill cancer cells. The new discoveries augment knowledge about the DDR by adding information on the function of specific proteins involved with BRCT-containing proteins.

"Our expectation is that the establishment of the BRCT-network will help identify potential sensitizers of therapy and accelerate the development of new therapeutic strategies," Monteiro said.

The research was supported in part by the U.S. Army Medical Research and Materiel Command, National Functional Genomics Center (W81XWH-08-2-0101), the Florida Breast Cancer Foundation, and the National Cancer Institute, part of the National Institutes of Health (P50-CA119997).

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by H. Lee Moffitt Cancer Center & Research Institute.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. N. T. Woods, R. D. Mesquita, M. Sweet, M. A. Carvalho, X. Li, Y. Liu, H. Nguyen, C. E. Thomas, E. S. Iversen, S. Marsillac, R. Karchin, J. Koomen, A. N. A. Monteiro. Charting the Landscape of Tandem BRCT Domain-Mediated Protein Interactions. Science Signaling, 2012; 5 (242): rs6 DOI: 10.1126/scisignal.2002255

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

Source: http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/genes/~3/sU8sBu-nPLo/121016085134.htm

david wright cory booker cubs cj wilson ellsbury brad pitt and angelina jolie brad and angelina

iPhone 5 generating more web traffic than Galaxy S3

iPhone 5 generating more web traffic than Galaxy S3

  • iOS 6 adoption booming despite Apple Maps troubles
  • Garmin tries to snatch iOS users with new features
  • Apple was warned by app developers over Maps app

Despite Apple?s current struggles with the much-maligned Maps app, the company is still enjoying quite a bit of success.

The iPhone 5 has already sold more than 5 million units, and iOS 6 is being adopted by users at an impressive rate.

Even though Maps? struggles have been highly publicized, there are still plenty of consumers interested in purchasing an iPhone 5.

A new study from ChangeWave not only revealed more consumers were interested in the iPhone 5 than they were the iPhone 4S, but also that an overwhelming percentage of Maps users had no issue with the app whatsoever.

Maps issues overhyped?

ChangeWave?s numbers found 19 percent of people polled were ?Very Likely? to purchase an iPhone 5.

When it ran a similar survey during the iPhone 4S? launch in October 2011, ChangeWave found just 10 percent of those polled answered the same way,

In fact, the iPhone 5 results outclassed those of the iPhone 4S in every single category in ChangeWave?s survey.

Additionally, ChangeWave polled current iOS 6 users in an effort to find out just how much of an issue Maps really was.

The majority of respondents, 90 percent, reported having no issue at all with Maps, while only 3 percent of those polled said Maps was a ?Very Big Problem.?

?In comparison to the iPhone 4 Antenna/Reception issue, the current Apple Maps issue is of marginal concern to iPhone 5/iOS 6 users,? said ChangWave in its report.

?Simply put, Apple Maps is not considered a problem by the overwhelming majority of users.?

iPhone 5 leads in web traffic

Perhaps even better news for Apple is the latest Chitika web browser report, which gives the iPhone 5 the lead over its competitor, the Samsung Galaxy S3.

With Apple already holding onto 72 percent of all smartphone web traffic, it should come as no surprise to learn the iPhone 5 is again leading the charge against its chief rival.

Pitting only the web traffic generated by the iPhone 5 against that of the Galaxy S3, Chitika found a slight majority in Apple?s favor.

The iPhone 5 is responsible for 56 percent of all web browsing between two smartphones, compared to the Galaxy S3?s 44 percent.

Considering the iPhone 5 is only a few weeks old, and Samsung?s smartphone has been out for months, that much of a gap already existing between the two is quite impressive.

Teamed with the record-breaking sales of the iPhone 5, Chitika said ?new 4G browsing speeds which encourage data usage, are the most likely explanation for this tremendous growth.?

If those ChangeWave poll-takers soon pick up an iPhone 5, that gap could grow even more before the end of the year.

Via BGR (1), (2), Chitika

Source: http://bestgadgets.site90.net/iphone-5-generating-more-web-traffic-than-galaxy-s3.html

national championship calipari national archives brock lesnar kentucky jayhawks wwe wrestlemania

Germany must act to solve "nightmare" euro crisis: Soros

{ttle}

{cptn}","template_name":"ss_thmb_play_ttle","i18n":{"end_of_gallery_header":"End of Gallery","end_of_gallery_next":"View Again"},"metadata":{"pagination":"{firstVisible} - {lastVisible} of {numItems}","ult":{"spaceid":"2145892301","sec":""}}},{"id": "hcm-carousel-780357651", "dataManager": C.dmgr, "mediator": C.mdtr, "group_name":"hcm-carousel-780357651", "track_item_selected":1,"tracking":{ "spaceid" : "2145892301", "events" : { "click" : { "any" : { "yui-carousel-prev" : { "node" : "a", "data" : {"sec":"HCMOL on article right rail","slk":"prev","itc":"1" }, "bubbles" : true, "test": function(params){ var carousel = params.obj.getCarousel(); var pages = carousel._pages; // if same page, don't beacon if(("_ult_current_page" in carousel) && carousel._ult_current_page==pages.cur) return false; // keep track of current position within this closure carousel._ult_current_page = pages.cur; return true; } }, "yui-carousel-next" : { "node" : "a", "data" : {"sec":"HCMOL on article right rail","slk":"next","itc":"1" }, "bubbles" : true, "test": function(params){ var carousel = params.obj.getCarousel(); var pages = carousel._pages; // no more pages, don't beacon again // if same page, don't beacon if(("_ult_current_page" in carousel) && carousel._ult_current_page==pages.cur) return false; // keep track of current position within this closure carousel._ult_current_page = pages.cur; return true; } } } } } } })); }); Y.later(10, this, function() {(function() { try{ if (Math.floor(Math.random()*10) == 1) { var loc = window.location, decoded = decodeURI(loc.pathname), encoded = encodeURI(decoded), uri = loc.protocol + "//" + loc.host + encoded + ((loc.search.length > 0) ? loc.search + '&' : '?') + "_cacheable=1", xmlhttp; if (window.XMLHttpRequest) xmlhttp = new XMLHttpRequest(); else xmlhttp = new ActiveXObject("Microsoft.XMLHTTP"); xmlhttp.open("GET",uri,true); xmlhttp.send(); } }catch(e){} })(); }); Y.later(10, this, function() {Y.namespace("Media").ywaSettings = '"projectId": "10001256862979", "documentName": "", "documentGroup": "", "ywaColo" : "vscale3", "spaceId" : "2145892301" ,"customFields" : { "12" : "classic", "13" : "story" }'; Y.Media.YWA.init(Y.namespace("Media").ywaSettings); }); Y.later(10, this, function() {if(document.onclick===YAHOO.Media.PreventDefaultHandler.newClick){document.onclick=YAHOO.Media.PreventDefaultHandler.oldClick;} }); }); });

Saturday, October 13, 2012

Prostate cancer: Curcumin curbs metastases, study shows

ScienceDaily (Oct. 12, 2012) ? Powdered turmeric has been used for centuries to treat osteoarthritis and other illnesses. Its active ingredient, curcumin, inhibits inflammatory reactions. A new study led by a research team at Ludwig-Maximilians-Universit?t (LMU) in Munich now shows that it can also inhibit formation of metastases.

Prostate cancer is one of the most prevalent malignancies in the Western world, and is often diagnosed only after metastatic tumors have formed in other organs. In three percent of cases, these metastases are lethal. A research team led by PD Dr. Beatrice Bachmeier at LMU Munich has been studying the mode of action of a natural product that inhibits the formation of metastases. The compound is found in turmeric, a plant that has been used for medicinal purposes for thousands of years, and is a major ingredient of curry.

Bachmeier's research centers on curcumin, the polyphenol responsible for the characteristic color of curry. Curcumin is well tolerated and is therefore, in principle, suitable both for prophylactic use (primary prevention) and also for the suppression of metastases in cases where an established tumor is already present (secondary prevention). In a previous study Bachmeier and her colleagues had demonstrated that the substance reduces statistically significantly the formation of lung metastases in an animal model of advanced breast cancer.

Mitigating metastasis The new study was designed to investigate the efficacy of curcumin in the prevention of prostate cancer metastases, and to determine the agent's mechanism of action. The researchers first examined the molecular processes that are abnormally regulated in prostate carcinoma cells. Breast and prostate cancers are often associated with latent or chronic inflammatory reactions, and in both cases, the tumor cells were found to produce pro-inflammatory immunomodulators including the cytokines CXCL1 und CXCL2.

The researchers went on to show that curcumin specifically decreases the expression of these two proteins, and in a mouse model, this effect correlated with a decline in the incidence of metastases. "Due to the action of curcumin, the tumor cells synthesize smaller amounts of cytokines that promote metastasis," says Bachmeier. "As a consequence, the frequency of metastasis formation in the lungs is significantly reduced, in animals with breast cancer, as we showed previously, or carcinoma of the prostate, as demonstrated in our new study."

Curcumin and chemoprevention Bachmeier therefore believes that curcumin may be useful in the prevention of breast and prostate cancers -- which are both linked to inflammation -- and in reducing their metastatic potential. "This does not mean that the compound should be seen as a replacement for conventional therapies. However, it could play a positive role in primary prevention -- before a full-blown tumor arises -- or help to avert formation of metastases. In this context the fact that the substance is well tolerated is very important, because one can safely recommend it to individuals who have an increased tumor risk."

A daily intake of up to 8g of curcumin is regarded as safe, and its anti-inflammatory properties have long been exploited in traditional oriental medicine. Men with benign hyperplasia of the prostate (BHP) are one possible target group for prophylaxis, as are women who have a family history of breast cancer. The agent might also be valuable as a supplement to certain cancer therapies. At all events, curcumin's beneficial effects must first be confirmed in controlled clinical tests. Bachmeier is now planning such a trial in patients who suffer from therapy-resistant carcinoma of the prostate.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by Ludwig-Maximilians-Universitaet Muenchen (LMU).

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. P. H. Killian, E. Kronski, K. Michalik, O. Barbieri, S. Astigiano, C. P. Sommerhoff, U. Pfeffer, A. G. Nerlich, B. E. Bachmeier. Curcumin Inhibits Prostate Cancer Metastasis in vivo by Targeting the Inflammatory Cytokines CXCL1 and -2. Carcinogenesis, 2012; DOI: 10.1093/carcin/bgs312

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

Source: http://feeds.sciencedaily.com/~r/sciencedaily/most_popular/~3/QFI47Y7nXJw/121012112152.htm

big east tournament ashley olsen new apple tv sun flare love hewitt new ipad solar flare

Tuesday, October 2, 2012

British Airways and University of Glamorgan Announce Engineering ...

CARDIFF, Wales, October 1, 2012 /PRNewswire/ --

Initiative brings world-leading technical training from Heathrow to South Wales

British Airways and the University of Glamorgan have signed a landmark agreement to combine technical training for one of the world's leading airlines with the enhanced career prospects of a university degree. ?Under the new initiative, to be accredited by the Civil Aviation Authority (CAA), engineers will graduate from Glamorgan with a BSc degree in Aircraft Maintenance Engineering having also completed the industry-standard EASA Part 66 training, awarded under British Airways' licence. ?The first intake of 100 students will enter the course in October. Engineering staff at British Airways will also have the opportunity to study academic modules from the University at undergraduate and postgraduate level.

Bill Kelly, General Manager Heavy Maintenance at British Airways, said: "We are delighted to be forming this relationship with the University of Glamorgan. British Airways employs over 1,400 people across three sites in South Wales, and this partnership will ensure that we continue to produce world-class engineers, ready to take on the challenge of maintaining our fleet. This is an exciting time for the airline, with next-generation aircraft such as the Boeing 787 and Airbus A380 presenting new challenges for our engineers. Partnering with the University of Glamorgan will allow us to develop the skills necessary to take our business forward."

The University of Glamorgan is one of the world's few institutions to have its own Aerospace Centre, a purpose-built ?2m facility in South Wales with its own airliner and flight simulator.

Professor Julie Lydon, Vice-Chancellor and Chief Executive of the University of Glamorgan, said: "As the largest airline in the UK and a global player in the aviation market, British Airways takes its relationship with education seriously. ?This initiative cements their links with Glamorgan, and we hope to develop our partnership further in the coming months. ?It's a win-win for British Airways, the University, and the graduates.

"This partnership is the only one of its kind in the UK, and is a testament to Glamorgan's reputation for excellence in the aviation industry. ?Glamorgan was founded by industry, for industry, as a specialist college of engineering, and we carry that forward today in ensuring that our aerospace students get both the technical skills to work on some of the world's leading aircraft, and the enhanced career prospects of a degree. ?The University of Glamorgan is well-recognised for being home to first-class facilities, and for producing graduates of an exceptional standard. ? Our partnership with British Airways is sure to give them a head start in their careers."

British Airways

http://www.britishairways.com?

British Airways is a global airline, flying to over 150 destinations in more than 70 countries. British Airways Engineering has a global reputation for engineering excellence and its technical and logistical expertise supports airline operations on every continent, 24 hours a day, 365 days a year. British Airways Engineering has three subsidiaries in South Wales, employing over 1,400 people: British Airways Maintenance Cardiff, British Airways Avionics Engineering, and British Airways Interiors Engineering.

The University of Glamorgan

http://www.glam.ac.uk

Founded by industry, for industry as a centre of engineering and management in 1913, the University of Glamorgan is a key international partner of major public and private sector employers. ?Rated in the UK's top ten universities for the lowest rate of unemployment among its graduates, 93% of Glamorgan students are in work or further study within six months of graduating. ?With 23,000 students from 122 countries on campuses in Cardiff and the South Wales valleys, the University includes two wholly-owned subsidiaries, The College at Merthyr Tydfil and Wales's national conservatoire, the Royal Welsh College of Music and Drama. ?With a strong commitment to social justice, Glamorgan opens opportunities to students from a diverse range of backgrounds and is a leading partner in UHOVI, the pioneering Universities' Heads of the Valleys Institute. ?With 70% of its research recognised as being of international standing, Glamorgan is one of the five members of the St David's Day Group of Wales's leading research-active universities. ?It plays a key role informing the policy debate on sustainable energy, the creative industries, public service reform, and economic growth. ?The University is an international leader in the use of ICT and simulation to deliver professional learning: facilities include its own airliner, court room, financial trading floor, HD television studios, computer animation renderfarm, scene of crime house, hospital simulation suite, and police control room. ?

NOTES TO EDITORS

High resolution images and footage available by contacting +44(0)1443-483362 and press@glam.ac.uk.

PRESS CONTACTS
University of Glamorgan
Public Affairs & Communications Team
Tom Griffin/Alexandra Harden/Jenna Hopkinson
+44(0)1443-483362
+44(0)7736-660538
press@glam.ac.uk

British Airways
Press Office
Ewan Fordyce
+44(0)208-738-5100
media.relations@ba.com?

SOURCE University of Glamorgan

Source: http://www.africanbusinessreview.co.za/press_releases/british-airways-and-university-of-glamorgan-announce-engineering-partnership

pineda john edwards heart condition mena suvari joyful noise one life to live jeff fisher van der sloot

The buzz: Flying robots may get bee brains

17 min.

Flying robots of the future may have the smarts of bees, a level of artificial intelligence with potential applications ranging from search and rescue missions to mechanical pollination of crops.

The first step in the Green Brain project underway at a pair of British universities is to develop accurate computer models of the neural systems that govern honey bee vision and sense of smell.?

Such smarts would, eventually, allow the team to build a flying robot that can sense and act as autonomously as a bee instead of carrying out a set of pre-programmed instructions.

The $1.3 million project is led by James Marshall at the University of Sheffield in collaboration with the University of Sussex.

According to a news release, understanding the brain of the socially complex honey bee is an alternative approach to artificial intelligence research, where other teams have focused on the brains of rats, monkeys and humans.

The bee brain is smaller and more accessible than any vertebrate brain, Marshall explained.?

In addition to building intelligent, autonomous robots, the research may lead to discoveries about what is causing wild honey bee populations around the world to plummet.?

Or, at least, contribute to the development of mechanical pollinators such as the Robobees project at Harvard University.

John Roach is a contributing writer for NBC News Digital. To learn more about him, check out his website. For more of our Future of Technology series, watch the featured video below.

Source: http://www.nbcnews.com/technology/futureoftech/buzz-flying-robots-may-get-bee-brains-6206727

sam young ncaa bracket ramon sessions portland trail blazers nba trade blagojevich new mexico state